Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Eli Lilly Pill Approval
Description
Eli Lilly received FDA approval for Foundayo, a once-daily weight-loss pill projected to generate $21B in global sales by 2030. The approval sets up direct competition with Novo Nordisk's Wegovy pill in the $70B+ GLP-1 market, despite Wegovy showing stronger 16.6% weight loss versus Foundayo's 12.4%.
Keywords & Tags
More from User
00:58
Nvidia's Robust Chip Growth
Benzinga
01:15
BYD Breaks Sales Slump
Benzinga
01:04
PM Cuts Outlook
Benzinga
00:58
Florida Sues OpenAI
Benzinga
00:53
SpaceX Eyes FCC Rule
Benzinga
00:54
Nvidida Eyes AI PCs
Benzinga
Related Videos
14:57
Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection
NDTV Profit
08:55
Le parcours de santé: Healthtech Investor Day, un événement pour donner de la visibilité à l’Europe dans les Biotechs - 21/06
BFM Business
01:50
AI Pharma Analytics Platform Explainer Video | HealthTech AI by MotionGility
Komal Chaturvedi
00:54
FDA Approves the Pfizer Vaccine, Now Called Comirnaty—Here's What FDA Approval Means
Health Magazine
01:54
FDA Dir. Gen. Domingo: Full approval ng US FDA sa Pfizer-Biontech vaccine, makakatulong sa pagpapaangat ng vaccine confidence | BT
GMA News
00:49
Novo Nordisk Jumps After FDA Grants Wegovy Approval For Liver Fibrosis, Unlocking Billions In Market Potential
Benzinga